| 562 |
561: Reduced, Food storage |
566: impaired, Larval development |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1557 |
1419: Reduced, FXR activity |
1420: Reduced, SHP activity |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1553 |
1415: Reduced, GABA-A receptor activation |
1416: Decreased, intracellular chloride |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 691 |
689: Reduced, Gonadotropin releasing hormone, hypothalamus |
690: Reduced, Luteinizing hormone (LH), plasma |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 2231 |
1008: Reduced, Hearing |
351: Increased Mortality |
Dec 8, 2020 |
Dec 8, 2020 |
1 AOP
|
| 1561 |
1423: Reduced, HSD17B4 activity |
1424: Reduced, fatty acid beta oxidation |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 692 |
690: Reduced, Luteinizing hormone (LH), plasma |
691: Reduced, Maturation inducing steroid, plasma |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 694 |
692: Reduced, Maturation inducing steroid receptor signalling, oocyte |
693: Increased, cyclic adenosine monophosphate |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 698 |
692: Reduced, Maturation inducing steroid receptor signalling, oocyte |
695: Upregulated, Spindle assembly checkpoint protein Mad2-oocyte |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 693 |
691: Reduced, Maturation inducing steroid, plasma |
692: Reduced, Maturation inducing steroid receptor signalling, oocyte |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 697 |
694: Reduced, Meiotic prophase I/metaphase I transition, oocyte |
675: Reduced, Reproductive Success |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1536 |
1405: Reduced, mucosal defense |
1385: Activated, gastric ulcer formation |
Jun 2, 2017 |
Jun 2, 2017 |
2 AOPs
|
| 1548 |
1405: Reduced, mucosal defense |
1412: Helicobacter pylori infection |
Jun 2, 2017 |
Jun 2, 2017 |
None
|
| 679 |
678: Reduced, Pheromone release |
674: Reduced, Ability to attract spawning mates |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1533 |
1403: Reduced, platelet aggregation |
1385: Activated, gastric ulcer formation |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1028 |
1004: Reduced, Posterior swim bladder inflation |
1005: Reduced, Swimming performance |
Nov 29, 2016 |
Sep 3, 2021 |
2 AOPs
|
| 1031 |
1004: Reduced, Posterior swim bladder inflation |
1007: Reduced, Anterior swim bladder inflation |
Nov 29, 2016 |
Nov 20, 2020 |
None
|
| 2213 |
1004: Reduced, Posterior swim bladder inflation |
351: Increased Mortality |
Nov 30, 2020 |
Sep 8, 2021 |
2 AOPs
|
| 1560 |
1422: Reduced, PPARalpha |
1423: Reduced, HSD17B4 activity |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 1551 |
1413: Reduced, presynaptic neuron 2 activity |
1414: Decreased, GABA |
Jun 2, 2017 |
Jun 2, 2017 |
1 AOP
|
| 357 |
383: Reduced, Presynaptic release of glutamate |
385: Synaptogenesis, Decreased |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 690 |
687: Reduced, Prostaglandin E2 concentration, hypothalamus |
689: Reduced, Gonadotropin releasing hormone, hypothalamus |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 672 |
671: Reduced, Prostaglandin F2alpha concentration, plasma |
673: Reduced, Spawning behavior |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 678 |
671: Reduced, Prostaglandin F2alpha concentration, plasma |
678: Reduced, Pheromone release |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 671 |
672: Reduced, Prostaglandin F2alpha synthesis, ovary |
671: Reduced, Prostaglandin F2alpha concentration, plasma |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|